{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:36:14Z","timestamp":1769121374992,"version":"3.49.0"},"reference-count":45,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.5551\/jat.46136","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T22:48:28Z","timestamp":1542149308000},"page":"528-537","source":"Crossref","is-referenced-by-count":9,"title":["Prestroke Aspirin Use is Associated with Clinical Outcomes in Ischemic Stroke Patients with Atherothrombosis, Small Artery Disease, and Cardioembolic Stroke"],"prefix":"10.5551","volume":"26","author":[{"given":"Jing","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Neurology, Third Affiliated Hospital of Wenzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyang","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Neurology, People's Hospital of Deyang City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Neurology, the Affiliated Hospital of Southwest Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Third Affiliated Hospital of Wenzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, People's Hospital of Deyang City"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA: Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke, 2014; 45: 3754-3832","DOI":"10.1161\/STR.0000000000000046"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lance, 2009; 373: 1849-1860","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bartolucci AA, Tendera M, Howard G: Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol, 2011; 107: 1796-1801","DOI":"10.1016\/j.amjcard.2011.02.325"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sanossian N, Saver JL, Rajajee V, Selco SL, Kim D, Razinia T, Ovbiagele B: Premorbid antiplatelet use and ischemic stroke outcomes. Neurology, 2006; 66: 319-323","DOI":"10.1212\/01.wnl.0000195889.05792.f1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Jung JM, Choi J, Eun MY, Seo WK, Cho KH, Yu S, Oh K, Hong S, Park KY: Prestroke antiplatelet agents in firstever ischemic stroke: clinical effects. Neurology, 2015; 84: 1080-1089","DOI":"10.1212\/WNL.0000000000001361"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) O'Donnell M, Oczkowski W, Fang J, Kearon C, Silva J, Bradley C, Guyatt G, Gould L, D'Uva C, Kapral M, Silver F: Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol, 2006; 5: 749-754","DOI":"10.1016\/S1474-4422(06)70536-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Park JM, Kang K, Cho YJ, Hong KS, Lee KB, Park TH, Lee SJ, Ko Y, Han MK, Lee J, Cha JK, Kim DH, Kim DE, Kim JT, Choi JC, Yu KH, Lee BC, Lee JS, Lee J, Gorelick PB, Bae HJ: Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome. Ann Neurol, 2016; 79: 560-568","DOI":"10.1002\/ana.24602"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Paciaroni M, Agnelli G, Caso V, Venti M, Alberti A, Milia P, Silvestrelli G, Biagini S: Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke. J Thromb Haemost, 2006; 4: 1957-1961","DOI":"10.1111\/j.1538-7836.2006.02095.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Rist PM, Buring JE, Kase CS, Kurth T: Effect of low-dose aspirin on functional outcome from cerebral vascular events in women. Stroke, 2013; 44: 432-436","DOI":"10.1161\/STROKEAHA.112.672451"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ricci S, Lewis S, Sandercock P; IST Collaborative Group: Previous use of aspirin and baseline stroke severity: an analysis of 17850 patients in the International Stroke Trial. Stroke, 2006; 37: 1737-1740","DOI":"10.1161\/01.STR.0000226740.29910.91"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kim WJ, Ko Y, Yang MH, Im SH, Park JH, Lee J, Lee J, Han MK, Bae HJ: Differential effect of previous antiplatelet use on stroke severity according to stroke mechanism. Stroke, 2010; 41: 1200-1204","DOI":"10.1161\/STROKEAHA.110.580225"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Lees KR, Bath PMW, Schellinger PD, Kerr DM, Fulton R, Hacke W, Matchar D, Sehra R, Toni D: Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke, 2012; 43: 1163-1170","DOI":"10.1161\/STROKEAHA.111.641423"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Yi X, Han Z, Zhou Q, Lin J, Liu P: 20-Hydroxyeicosatetraenoic Acid as a Predictor of Neurological Deterioration in Acute Minor Ischemic Stroke. Stroke, 2016; 47: 3045- 3047","DOI":"10.1161\/STROKEAHA.116.015146"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Vahidy FS, Hicks WJ 2nd, Acosta I, Hallevi H, Peng H, Pandurengan R, Gonzales NR, Barreto AD, Martin-Schild S, Wu TC, Rahbar MH, Bambhroliya AB, Grotta JC, Savitz SI: Neurofluctuation in patients with subcortical ischemic stroke. Neurology, 2014; 83: 398-405","DOI":"10.1212\/WNL.0000000000000643"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wang C, Yi X, Zhang B, Liao D, Lin J, Chi L: Clopidogrel plus aspirin prevents early neurologic deterioration and improves 6-month outcome in patients with acute large artery atherosclerosis stroke. Clin Appl Thromb Hemost, 2015; 21: 453-461","DOI":"10.1177\/1076029614551823"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yi X, Lin J, Wang C, Zhang B, Chi W: A comparative study of dual versus monoantiplatelet therapy in patients with acute large-artery atherosclerosis stroke. J Stroke Cerebrovasc Dis, 2014; 23: 1975-1981","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.022"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yi X, Wang C, Liu P, Fu C, Lin J, Chen Y: Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population. J Neurol, 2016; 263: 1612-1629","DOI":"10.1007\/s00415-016-8181-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yi X, Han Z, Wang C, Zhou Q, Lin J: Statin and Aspirin Pretreatment Are Associated with Lower Neurological Deterioration and Platelet Activity in Patients with Acute Ischemic Stroke. J Stroke Cerebrovasc Dis, 2017; 26: 352-359","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.030"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Bufalino VJ, Masoudi FA, Stranne SK, Horton K, Albert NM, Beam C, Bonow RO, Davenport RL, Girgus M, Fonarow GC, Krumholz HM, Legnini MW, Lewis WR, Nichol G, Peterson ED, Rumsfeld JS, Schwamm LH, Shahian DM, Spertus JA, Woodard PK, Yancy CW: The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation, 2011; 123: 2167-2179","DOI":"10.1161\/CIR.0b013e3182181529"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Han SW, Kim SH, Lee JY, Chu CK, Yang JH, Shin HY, Nam HS, Lee BI, Heo JH: A new subtype classification of ischemic stroke based on treatment and etiologic mechanism. Eur Neurol, 2007; 57: 96-102","DOI":"10.1159\/000098059"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Toni D, Fiorelli M, Bastianello S, Sacchetti ML, Sette G, Argentino C, Montinaro E, Bozzao L: Hemorrhagic transformation of brain infarcts: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology, 1996; 46: 341-345","DOI":"10.1212\/WNL.46.2.341"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Scott SC, Goldberg MS, Mayo NE: Statistical assessment of ordinal outcomes in comparative studies. J Clin Epidemiol, 1997; 50: 45-55","DOI":"10.1016\/S0895-4356(96)00312-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell D: 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke, 2018; 49: e46-e110","DOI":"10.1161\/STR.0000000000000158"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rosenblum WI, El-Sabban F: Platelet aggregation in the cerebral microcirculation: effect of aspirin and other agents. Circ Res, 1977; 40: 320-328","DOI":"10.1161\/01.RES.40.3.320"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Joseph R, D'Andrea G, Oster SB, Welch KM: Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents. Stroke, 1989; 20: 38-44","DOI":"10.1161\/01.STR.20.1.38"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Joseph R, Han E, Tsering C, Grunfeld S, Welch KM: Platelet activity and stroke severity. J Neurol Sci, 1992; 108: 1-6","DOI":"10.1016\/0022-510X(92)90180-S"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Riepe MW, Kasischke K, Raupach A: Acetylsalicylic acid increases tolerance against hypoxic and chemical hypoxia. Stroke, 1997; 28: 2006-2011","DOI":"10.1161\/01.STR.28.10.2006"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Grilli M, Pizzi M, Memo M, Spano P: Neuroprotection by aspirin and sodium salicylate through blockade of NF-jB activation. Science, 1996; 274: 1383-1385","DOI":"10.1126\/science.274.5291.1383"},{"key":"29","unstructured":"29) Kuhn W, Muller T, Bttner T, Gerlach M: Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia. Stroke, 1995; 26: 1959-1960"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Inzitari D, Eliasziw M, Gates P, Sharpe BL, Chan RK, Meldrum HE, Barnett HJ: The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med, 2000; 342: 1693-1700","DOI":"10.1056\/NEJM200006083422302"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Grotta JC, Lemak NA, Gary H, Fields WS, Vital D: Does platelet antiaggregant therapy lessen the severity of stroke? Neurology, 1985; 35: 632-636","DOI":"10.1212\/WNL.35.5.632"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) The SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA: Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med, 2012; 367: 817-825","DOI":"10.1056\/NEJMoa1204133"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Hart RG, Pearce LA, Aguilar MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007; 146: 857-867","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW: 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 2014; 130: e199-e267","DOI":"10.1161\/CIR.0000000000000040"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Vila N, Castillo J, Davalos A, Chamorro A: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke, 2000; 31: 2325-2329","DOI":"10.1161\/01.STR.31.10.2325"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Yi X, Lin J, Wang Y, Zhou J, Zhou Q, Wang C: Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke. Oncotarget, 2018; 9: 19900-19910","DOI":"10.18632\/oncotarget.24945"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, Calleja S, Garami Z, Khan K, Akhtar N, O'Rourke F, Shuaib A, Demchuk AM, Alexandrov AV: Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke, 2007; 38: 69-74","DOI":"10.1161\/01.STR.0000251800.01964.f6"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Jung JM, Choi J, Eun MY, Seo WK, Cho KH, Yu S, Oh K, Hong S, Park KY: Prestroke antiplatelet agents in firstever ischemic stroke: clinical effects. Neurology, 2015; 84: 1080-1089","DOI":"10.1212\/WNL.0000000000001361"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Diedler J, Ahmed N, Sykora M, Uyttenboogaart M, Overgaard K, Luijckx GJ, Soinne L, Ford GA, Lees KR, Wahlgren N, Ringleb P: Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke, 2010; 41: 288-294","DOI":"10.1161\/STROKEAHA.109.559724"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Xian Y, Federspiel JJ, Grau-Sepulveda M, Hernandez AF, Schwamm LH, Bhatt DL, Smith EE, Reeves MJ, Thomas L, Webb L, Bettger JP, Laskowitz DT, Fonarow GC, Peterson ED: Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. JAMA Neurol, 2016; 73: 50-59","DOI":"10.1001\/jamaneurol.2015.3106"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Tsivgoulis G, Katsanos AH, Zand R, Sharma VK, K\u00f6hrmann M, Giannopoulos S, Dardiotis E, Alexandrov AW, Mitsias PD, Schellinger PD, Alexandrov AV: Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis. J Neurol, 2017; 264: 1227-1235","DOI":"10.1007\/s00415-017-8520-1"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Wouters A, Nysten C, Thijs V, Lemmens R: Prediction of Outcome in Patients With Acute Ischemic Stroke Based on Initial Severity and Improvement in the First 24 h. Front Neurol , 2018; 9: 308","DOI":"10.3389\/fneur.2018.00308"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Fateh-Moghadam S, Li Z, Ersel S, Reuter T, Htun P, Plockinger U, Bocksch W, Dietz R, Gawaz M: Platelet degranulation is associated with progression of intimamedia thickness of the common carotid artery in patients with diabetes mellitus type 2. Arterioscler Thromb Vasc Biol 2005; 25: 1299-1303","DOI":"10.1161\/01.ATV.0000165699.41301.c5"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Xian Y, O'Brien EC, Liang L, Xu H, Schwamm LH, Fonarow GC, Bhatt DL, Smith EE, Olson DM, Maisch L, Hannah D, Lindholm B, Lytle BL, Pencina MJ, Hernandez AF, Peterson ED: Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation. JAMA, 2017; 317: 1057-1067","DOI":"10.1001\/jama.2017.1371"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Paciaroni M, Agnelli G, Caso V, Venti M, Alberti A, Milia P, Silvestrelli G, Biagini S: Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke. J Thromb Haemost, 2006; 4: 1957-1961","DOI":"10.1111\/j.1538-7836.2006.02095.x"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/6\/26_46136\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:06:35Z","timestamp":1559361995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/6\/26_46136\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.46136","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}